Found: 45
Select item for more details and to access through your institution.
Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A longer duration of red blood cell storage is associated with a lower hemoglobin increase after blood transfusion: a cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel.
- Published in:
- Genes, Chromosomes & Cancer, 2024, v. 63, n. 7, p. 1, doi. 10.1002/gcc.23257
- By:
- Publication type:
- Article
The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 11, p. 672, doi. 10.1002/gcc.23184
- By:
- Publication type:
- Article
Myeloid leukaemia in systemic lupus erythematosus—a nested case–control study based on Swedish registers.
- Published in:
- Rheumatology, 2009, v. 48, n. 10, p. 1222, doi. 10.1093/rheumatology/kep204
- By:
- Publication type:
- Article
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.
- Published in:
- Nature Communications, 2015, v. 6, n. 1, p. 5901, doi. 10.1038/ncomms6901
- By:
- Publication type:
- Article
Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 1993, v. 44, n. 4, p. 229, doi. 10.1002/ajh.2830440403
- By:
- Publication type:
- Article
Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT‐positivity, and increased transfusion needs.
- Published in:
- Transfusion, 2023, v. 63, n. 11, p. 2040, doi. 10.1111/trf.17562
- By:
- Publication type:
- Article
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06063-x
- By:
- Publication type:
- Article
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 2, p. 272, doi. 10.1111/j.1365-2141.2011.08672.x
- By:
- Publication type:
- Article
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 3, p. 293, doi. 10.1111/j.1365-2141.2010.08235.x
- By:
- Publication type:
- Article
Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 6, p. 844, doi. 10.1111/j.1365-2141.2010.08174.x
- By:
- Publication type:
- Article
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 2, p. 244, doi. 10.1111/j.1365-2141.2010.08082.x
- By:
- Publication type:
- Article
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 1, p. 86, doi. 10.1111/j.1365-2141.2009.07720.x
- By:
- Publication type:
- Article
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 1, p. 57, doi. 10.1111/j.1365-2141.2008.07178.x
- By:
- Publication type:
- Article
Gene expression profiling of CD34<sup>+</sup> cells in patients with the 5q− syndrome.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 4, p. 578, doi. 10.1111/j.1365-2141.2007.06833.x
- By:
- Publication type:
- Article
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 6, p. 1037, doi. 10.1046/j.1365-2141.2003.04153.x
- By:
- Publication type:
- Article
Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases.
- Published in:
- British Journal of Haematology, 2001, v. 112, n. 3, p. 714, doi. 10.1046/j.1365-2141.2001.02581.x
- By:
- Publication type:
- Article
appreci8: a pipeline for precise variant calling integrating 8 tools.
- Published in:
- Bioinformatics, 2018, v. 34, n. 24, p. 4205, doi. 10.1093/bioinformatics/bty518
- By:
- Publication type:
- Article
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 5, p. 439, doi. 10.1111/ejh.12383
- By:
- Publication type:
- Article
Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 3, p. 259, doi. 10.1111/ejh.12045
- By:
- Publication type:
- Article
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 3, p. 244, doi. 10.1111/j.1600-0609.2011.01654.x
- By:
- Publication type:
- Article
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 130, doi. 10.1111/j.1600-0609.2010.01456.x
- By:
- Publication type:
- Article
Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
- Published in:
- European Journal of Haematology, 1996, v. 56, n. 3, p. 124, doi. 10.1111/j.1600-0609.1996.tb01330.x
- By:
- Publication type:
- Article
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts.
- Published in:
- PLoS ONE, 2008, v. 3, n. 4, p. 1, doi. 10.1371/journal.pone.0001970
- By:
- Publication type:
- Article
Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 451, doi. 10.1111/bjh.18542
- By:
- Publication type:
- Article
Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 474, doi. 10.1111/bjh.16790
- By:
- Publication type:
- Article
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 614, doi. 10.1111/bjh.15243
- By:
- Publication type:
- Article
Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 526, doi. 10.1111/bjh.15094
- By:
- Publication type:
- Article
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 478, doi. 10.1111/bjh.13610
- By:
- Publication type:
- Article
Validation of the revised international prognostic scoring system ( IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS ( EUMDS) registry.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 372, doi. 10.1111/bjh.13450
- By:
- Publication type:
- Article
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 4, p. 610, doi. 10.1111/bjh.12655
- By:
- Publication type:
- Article
Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data.
- Published in:
- Scientific Reports, 2017, p. 43169, doi. 10.1038/srep43169
- By:
- Publication type:
- Article
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 12, p. 2697, doi. 10.1002/cncr.25774
- By:
- Publication type:
- Article
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sixth International Symposium on Myelodysplastic Syndromes, Stockholm, June 14-17, 2001.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Lead poisoning from souvenir earthenware.
- Published in:
- International Archives of Occupational & Environmental Health, 2006, v. 79, n. 2, p. 165, doi. 10.1007/s00420-005-0037-8
- By:
- Publication type:
- Article
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0491-2
- By:
- Publication type:
- Article
Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 4, p. 966, doi. 10.1046/j.1365-2141.1999.01442.x
- By:
- Publication type:
- Article
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.
- Published in:
- British Journal of Haematology, 1997, v. 99, n. 2, p. 344, doi. 10.1046/j.1365-2141.1997.4013211.x
- By:
- Publication type:
- Article
A predictive model for the clinical response to low dose ara- C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia.
- Published in:
- British Journal of Haematology, 1992, v. 81, n. 4, p. 503, doi. 10.1111/j.1365-2141.1992.tb02982.x
- By:
- Publication type:
- Article
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- Published in:
- Annals of Hematology, 2015, v. 94, n. 1, p. 23, doi. 10.1007/s00277-014-2177-y
- By:
- Publication type:
- Article
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 4, p. 365, doi. 10.1007/s00277-009-0846-z
- By:
- Publication type:
- Article